Sutro Biopharma Stock Price History
| STRO Stock | USD 1.95 0.07 3.72% |
Below is the normalized historical share price chart for Sutro Biopharma extending back to September 27, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Sutro Biopharma stands at 1.95, as last reported on the 31st of January, with the highest price reaching 1.98 and the lowest price hitting 1.87 during the day.
If you're considering investing in Sutro Stock, it is important to understand the factors that can impact its price. Sutro Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.18, which indicates the firm had a -0.18 % return per unit of risk over the last 3 months. Sutro Biopharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sutro Biopharma's Risk Adjusted Performance of (0.11), variance of 26.86, and Coefficient Of Variation of (712.96) to confirm the risk estimate we provide.
At this time, Sutro Biopharma's Common Stock Shares Outstanding is very stable compared to the past year. As of the 31st of January 2025, Other Stockholder Equity is likely to grow to about 856.1 M, while Total Stockholder Equity is likely to drop about 134.9 M. . As of the 31st of January 2025, Price To Sales Ratio is likely to drop to 1.44. In addition to that, Price Earnings Ratio is likely to grow to -2.64. Sutro Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date | 200 Day MA 3.4346 | 50 Day MA 2.235 | Beta 1.168 |
Sutro |
Sharpe Ratio = -0.1823
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | STRO |
Estimated Market Risk
| 5.15 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.94 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.18 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sutro Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sutro Biopharma by adding Sutro Biopharma to a well-diversified portfolio.
Price Book 1.3938 | Enterprise Value Ebitda 0.4055 | Price Sales 0.999 | Shares Float 69.3 M | Wall Street Target Price 11.5 |
Sutro Biopharma Stock Price History Chart
There are several ways to analyze Sutro Stock price data. The simplest method is using a basic Sutro candlestick price chart, which shows Sutro Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 11, 2024 | 4.4 |
| Lowest Price | January 14, 2025 | 1.72 |
Sutro Biopharma January 31, 2025 Stock Price Synopsis
Various analyses of Sutro Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Sutro Stock. It can be used to describe the percentage change in the price of Sutro Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Sutro Stock.| Sutro Biopharma Price Rate Of Daily Change | 1.04 | |
| Sutro Biopharma Price Action Indicator | 0.06 | |
| Sutro Biopharma Price Daily Balance Of Power | 0.64 | |
| Sutro Biopharma Accumulation Distribution | 45,046 |
Sutro Biopharma January 31, 2025 Stock Price Analysis
Sutro Stock Price History Data
The price series of Sutro Biopharma for the period between Sat, Nov 2, 2024 and Fri, Jan 31, 2025 has a statistical range of 2.68 with a coefficient of variation of 29.95. The price distribution for the period has arithmetic mean of 2.59. The median price for the last 90 days is 2.45.| Open | High | Low | Close | Volume | ||
| 01/30/2025 | 1.91 | 1.98 | 1.87 | 1.95 | 810,836 | |
| 01/29/2025 | 1.93 | 1.96 | 1.81 | 1.88 | 724,763 | |
| 01/28/2025 | 1.98 | 1.98 | 1.85 | 1.90 | 865,945 | |
| 01/27/2025 | 2.04 | 2.11 | 1.95 | 1.99 | 646,082 | |
| 01/24/2025 | 2.00 | 2.15 | 1.98 | 2.04 | 621,917 | |
| 01/23/2025 | 1.93 | 2.07 | 1.88 | 2.03 | 893,570 | |
| 01/22/2025 | 1.99 | 2.02 | 1.92 | 1.97 | 746,913 | |
| 01/21/2025 | 2.07 | 2.07 | 1.91 | 1.99 | 915,439 | |
| 01/17/2025 | 1.88 | 2.08 | 1.84 | 2.01 | 1,311,720 | |
| 01/16/2025 | 1.85 | 1.85 | 1.72 | 1.85 | 872,421 | |
| 01/15/2025 | 1.78 | 1.84 | 1.75 | 1.83 | 829,160 | |
| 01/14/2025 | 1.82 | 1.82 | 1.67 | 1.72 | 921,154 | |
| 01/13/2025 | 1.84 | 1.84 | 1.71 | 1.79 | 599,575 | |
| 01/10/2025 | 1.95 | 1.95 | 1.78 | 1.85 | 952,010 | |
| 01/08/2025 | 2.03 | 2.03 | 1.93 | 1.95 | 742,636 | |
| 01/07/2025 | 2.09 | 2.15 | 2.00 | 2.02 | 774,579 | |
| 01/06/2025 | 1.99 | 2.09 | 1.95 | 2.04 | 900,229 | |
| 01/03/2025 | 1.95 | 2.00 | 1.91 | 1.95 | 829,982 | |
| 01/02/2025 | 1.86 | 2.06 | 1.86 | 1.93 | 1,083,273 | |
| 12/31/2024 | 1.85 | 1.90 | 1.80 | 1.84 | 775,421 | |
| 12/30/2024 | 1.89 | 1.89 | 1.81 | 1.85 | 809,916 | |
| 12/27/2024 | 1.98 | 2.01 | 1.83 | 1.89 | 803,798 | |
| 12/26/2024 | 1.91 | 1.97 | 1.85 | 1.97 | 561,627 | |
| 12/24/2024 | 1.85 | 1.93 | 1.83 | 1.93 | 485,455 | |
| 12/23/2024 | 1.90 | 1.92 | 1.82 | 1.87 | 709,027 | |
| 12/20/2024 | 1.79 | 1.93 | 1.77 | 1.88 | 2,345,201 | |
| 12/19/2024 | 1.98 | 1.98 | 1.70 | 1.82 | 1,542,262 | |
| 12/18/2024 | 2.07 | 2.12 | 1.81 | 1.85 | 1,830,171 | |
| 12/17/2024 | 2.07 | 2.14 | 2.03 | 2.09 | 1,655,211 | |
| 12/16/2024 | 2.12 | 2.19 | 2.05 | 2.07 | 1,717,463 | |
| 12/13/2024 | 2.18 | 2.23 | 2.08 | 2.12 | 1,639,834 | |
| 12/12/2024 | 2.44 | 2.48 | 2.19 | 2.20 | 1,660,453 | |
| 12/11/2024 | 2.38 | 2.48 | 2.31 | 2.45 | 1,239,936 | |
| 12/10/2024 | 2.79 | 2.84 | 2.32 | 2.35 | 3,618,453 | |
| 12/09/2024 | 2.91 | 3.01 | 2.81 | 2.81 | 1,090,752 | |
| 12/06/2024 | 2.83 | 2.93 | 2.74 | 2.84 | 1,319,314 | |
| 12/05/2024 | 2.85 | 2.87 | 2.71 | 2.78 | 1,186,176 | |
| 12/04/2024 | 2.76 | 2.85 | 2.70 | 2.84 | 1,493,489 | |
| 12/03/2024 | 2.76 | 2.86 | 2.66 | 2.76 | 2,135,830 | |
| 12/02/2024 | 2.74 | 2.82 | 2.69 | 2.75 | 864,952 | |
| 11/29/2024 | 2.72 | 2.75 | 2.64 | 2.65 | 723,064 | |
| 11/27/2024 | 2.61 | 2.76 | 2.60 | 2.69 | 574,434 | |
| 11/26/2024 | 2.65 | 2.68 | 2.55 | 2.60 | 650,381 | |
| 11/25/2024 | 2.60 | 2.71 | 2.57 | 2.61 | 909,863 | |
| 11/22/2024 | 2.52 | 2.60 | 2.45 | 2.51 | 843,693 | |
| 11/21/2024 | 2.66 | 2.77 | 2.52 | 2.53 | 925,098 | |
| 11/20/2024 | 2.70 | 2.81 | 2.55 | 2.67 | 884,921 | |
| 11/19/2024 | 2.73 | 2.87 | 2.65 | 2.70 | 2,925,326 | |
| 11/18/2024 | 2.91 | 2.95 | 2.60 | 2.75 | 1,170,456 | |
| 11/15/2024 | 3.46 | 3.46 | 2.82 | 2.89 | 1,546,798 | |
| 11/14/2024 | 3.89 | 4.06 | 3.42 | 3.45 | 702,562 | |
| 11/13/2024 | 4.16 | 4.25 | 3.96 | 3.96 | 245,288 | |
| 11/12/2024 | 4.34 | 4.34 | 4.08 | 4.08 | 397,189 | |
| 11/11/2024 | 4.47 | 4.60 | 4.25 | 4.40 | 777,708 | |
| 11/08/2024 | 4.12 | 4.46 | 4.01 | 4.38 | 518,752 | |
| 11/07/2024 | 4.14 | 4.41 | 4.11 | 4.16 | 577,675 | |
| 11/06/2024 | 3.87 | 4.24 | 3.86 | 4.14 | 829,072 | |
| 11/05/2024 | 3.71 | 3.86 | 3.60 | 3.84 | 519,412 | |
| 11/04/2024 | 3.49 | 3.72 | 3.36 | 3.69 | 801,474 | |
| 11/01/2024 | 3.35 | 3.74 | 3.33 | 3.55 | 1,242,789 | |
| 10/31/2024 | 3.53 | 3.54 | 3.22 | 3.25 | 448,797 |
About Sutro Biopharma Stock history
Sutro Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sutro is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sutro Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sutro Biopharma stock prices may prove useful in developing a viable investing in Sutro Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 69.2 M | 72.6 M | |
| Net Loss | -107.3 M | -101.9 M |
Sutro Biopharma Quarterly Net Working Capital |
|
Sutro Biopharma Stock Technical Analysis
Sutro Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
| All Next | Launch Module |
Sutro Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sutro Biopharma's price direction in advance. Along with the technical and fundamental analysis of Sutro Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sutro to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.83) | |||
| Total Risk Alpha | (1.29) | |||
| Treynor Ratio | (0.74) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sutro Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Sutro Stock, please use our How to Invest in Sutro Biopharma guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sutro Biopharma. If investors know Sutro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sutro Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.55) | Revenue Per Share | Quarterly Revenue Growth (0.50) | Return On Assets | Return On Equity |
The market value of Sutro Biopharma is measured differently than its book value, which is the value of Sutro that is recorded on the company's balance sheet. Investors also form their own opinion of Sutro Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sutro Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sutro Biopharma's market value can be influenced by many factors that don't directly affect Sutro Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sutro Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sutro Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sutro Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.